NextPlat to Launch ClearMetrX 4.0, an AI-Driven Healthcare Analytics Suite for Efficiency, Adherence, and Compliance

ClearMetrX 4.0 brings AI-driven healthcare analytics to the point of decision

NextPlat Corp announced that its ClearMetrx subsidiary is in late-stage development of ClearMetrX 4.0, an AI-powered upgrade to its healthcare analytics and reporting platform. Internal rollout is slated for Q4 2025, with broader commercialization planned for the first half of 2026.

Built for physicians, MSOs, 340B entities, and pharmacies, ClearMetrX centralizes reporting and operational analytics across care and pharmacy workflows. The 4.0 release adds AI to streamline how organizations collect, analyze, and act on their data to improve efficiency and patient adherence.

Market momentum supports this move. The global AI in healthcare market was estimated at $26.57B in 2024 and is projected to reach $187.69B by 2030, according to Grand View Research, reflecting sustained demand for efficiency, accuracy, and better outcomes. Source

What's new in ClearMetrX 4.0

• Revenue forecasting: AI/ML models to predict revenue, prescription volumes, and patient demand.
• Predictive inventory management: Forecasting to optimize stock levels and reduce shortages or waste.
• Anomaly and exception detection: Real-time signals on abnormal prescribing, dispensing, or claims patterns.
• Audit assistance, analytics, and reporting: Dashboards that automate evidence gathering, compliance reporting, and actionable analytics.
• Fraud detection: Advanced analytics to surface suspicious billing or dispensing activity.
• What-if simulations: Scenario modeling to assess financial and compliance outcomes before making changes.

Why it matters for care delivery and operations

Healthcare teams need visibility they can act on. ClearMetrX 4.0 focuses on practical levers: demand and revenue forecasting for budgeting, inventory right-sizing to prevent waste, and faster audits to reduce administrative burden.

Real-time anomaly detection helps teams intervene sooner-whether the issue is a claims pattern, adherence slip, or dispensing irregularity. Scenario modeling supports proactive decisions on policy, staffing, and formulary choices with quantified impact.

Rollout and access

ClearMetrX 4.0 will be deployed internally in Q4 2025, with availability to customers in H1 2026. The platform is already in use across NextPlat pharmacies and its client network.

To request information or schedule a demonstration, visit clearmetrx.com. For company information, visit NextPlat.com.

Leadership perspective

"ClearMetrX has shown it can improve the business of healthcare and support better outcomes through improved patient adherence," said Birute Norkute, Vice President of Healthcare Operations at NextPlat. "With ClearMetrX 4.0, we're applying AI to improve efficiency and effectiveness for all stakeholders."

Forward-looking note

Timelines, features, and performance expectations are subject to risks and uncertainties. For details on risk factors, see the Company's filings with the SEC at sec.gov.